BIOTON S.A. (WSE:BIO)
3.930
-0.050 (-1.26%)
Jun 16, 2026, 3:26 PM CET
BIOTON Revenue
BIOTON had revenue of 49.12M PLN in the quarter ending March 31, 2026, a decrease of -25.15%. This brings the company's revenue in the last twelve months to 266.02M, up 12.77% year-over-year. In the year 2025, BIOTON had annual revenue of 282.52M with 35.98% growth.
Revenue (ttm)
266.02M
Revenue Growth
+12.77%
P/S Ratio
1.28
Revenue / Employee
732.84K
Employees
364
Market Cap
341.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 282.52M | 74.76M | 35.98% |
| Dec 31, 2024 | 207.76M | 26.13M | 14.38% |
| Dec 31, 2023 | 181.64M | -51.52M | -22.10% |
| Dec 31, 2022 | 233.16M | 70.13M | 43.01% |
| Dec 31, 2021 | 163.03M | -58.75M | -26.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ryvu Therapeutics | 88.38M |
| Synthaverse | 42.19M |
| Mabion | 17.61M |
| Molecure | 6.52M |
| Urteste | 2.50M |
| Captor Therapeutics Spolka Akcyjna | 2.38M |
| Pharmena | 1.61M |
| Poltreg | 250.00K |